Live Alaska CME Cruise June 30-July 7, 2018

Inside Passage Cruise from Seattle aboard Ruby Princess

alaska-cme-conference-credit-hours-live

Conference as low as $650

Cruise as low as $954

Registration Deadline
Discounted Advanced Registration expires April 10, 2018.

Destinations
Seattle, Juneau, Skagway, Glacier Bay National Park (scenic cruising), Ketchikan, AK and Victoria, BC

Patient Safety, Drug Abuse, Psychiatry and Pharmacogenomics - Alaska Cruise 2018 | June 30 - July 7, 2018 | Ruby Princess

Join University Learning Systems aboard the stunning Ruby Princess, June 30 - July 7, 2018 for live CE, CME, CNE, Patient Safety, Drug Abuse, Psychiatry and Pharmacogenomics. 

Pharmacists, Family Medicine Physicians, Nurse Practitioners and Physician Assistants will find this annual update invaluable to their daily practice. 

This inside passage Alaska cruise departs from Seattle, WA and includes stops in the Juneau, Skagway, Glacier Bay National Park (scenic cruising), Ketchikan and Victoria, British Columbia. This program in its entirety provides 15 contact hours (1.5 CEU) over three days, 5 hours per day, of live AAFP/ AMA PRA Category 1™, ACPE and pharmacology CE/ CME credit.

Want more information?

Itinerary

 

 

 

DayDatePortArriveDepart
130 June 2018Seattle, WA04:00 PM
21 July 2018At Sea
32 July 2018Juneau, AK11:00 AM10:00 PM
43 July 2018Skagway, AK06:00 AM08:15 PM
54 July 2018Glacier Bay National Park (scenic cruising)06:00 AM03:00 PM
65 July 2018Ketchikan, AK07:00 AM01:00 PM
76 July 2018Victoria, British Columbia, Canada07:00 PM12:00 PM
87 July 2018Seattle, WA07:00 AM

 

 

 

Princess Cruises Featured Videos

Cruise Fees

All rates are per person based on double occupancy.

  • Interior Cabin  (ID) $954
  • Interior Cabin (IF) $979
  • Ocean View Stateroom  (OF)  $1554
  • Ocean View Stateroom (OC) $1589
  • Balcony Stateroom  (BD)   $2054
  • Balcony Stateroom (BC) $2099
  • Balcony Stateroom (BB) $2144
  • Mini-Suite with Balcony (MD) $2454
  • Mini-Suite with Balcony (MB) $2509
  • Other categories subject to availability.
  • Port charges, taxes, fees $470.00

Refundable Deposit: 20% of cruise fare, per person

Cancellation Policy: Cancellation policies vary by cruise line, itinerary and length of cruise. When reserving your stateroom, please review the policy applicable to this cruise with University at Sea staff.

How to Book Your Cruise

Cruise Reservations Contact:
University at Sea: 1-800-926-3775 or click here.

Final payment due by April 10, 2018

All conferees, their families, and guests must book their cruise within the University at Sea® meeting group through University at Sea® at 800-926-3775 or click here to reserve online. This ensures our company can provide conference services and complimentary social amenities to all meeting participants and their guests. Conference attendees who book outside of this group will be charged a $300/cabin surcharge at time of registration.

Quick Facts

  • Cruise departs and returns to Seattle, WA.
  • Passport required.
  • Refundable deposit of 20% cruise fare per person is due at time of booking.
  • Rates listed below do not include port charges, government fees and taxes of $470.00
  • Travel insurance available for purchase; contact University at Sea. ULS recommends trip cancellation insurance.
  • Round-trip transfers are additional.
  • Other cabin categories are subject to availability.
  • Prices are subject to change without notice.
  • Attendees who book outside of group will be charged $300/cabin surcharge at point of registration.

Conference Registration

Physicians, Dentists
*Discounted Advanced Registration – $795
Regular Registration – $845

Physician Assistants, Nurse Practitioners, Pharmacists, Nurses
*Discounted Advanced Registration – $650
Regular Fee – $695

*Discounted Advanced Registration Deadline: April 10, 2018

Registration Details

Conference registration includes workshop attendance, handouts and refreshments during the meetings and documentation of continuing education credit*.

Spouses, family and friends are welcome and do not need to register unless they attend the educational sessions. Special conference fees are available for non-professional accompanying persons who wish to attend one or more session (no special receipt, certification or credit issued).

Conference Credit

University Learning Systems ACPE Pharmacy CE

University Learning Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. All programs are accredited for pharmacists.

  • Session 1: 5 Contact Hours ACPE UAN 0741-0000-18-016-L01-P, Activity: Knowledge
  • Session 2: 2.5 Contact Hours ACPE UAN 0741-0000-18-017-L01-P, Activity: Knowledge
  • Session 3: 2.5 Contact Hours ACPE UAN 0741-0000-18-018-L01-P, Activity: Knowledge
  • Session 4A: 2 Contact Hours ACPE UAN 0741-0000-18-019-L01-P, Activity: Knowledge
  • Session 4B: 3 Contact Hours ACPE UAN 0741-0000-18-020-L05-P, Activity: Knowledge

Physicians:  Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.  AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credit™ toward the AMA Physician’s Recognition Award.  When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

Accreditation

Conference Policies

Pharmacogenomics : Guided therapy in Psychiatry,  Cardiology and Oncology (5 hrs)

Date: Sunday, 7/1/2018

Breakfast on your own
Check-in: 7:45 AM
Educational Session: 8:00 AM – 1:30 PM

Pharmacodynamic and pharmacokinetic genetic variations can have a tremendous impact on drug efficacy. Knowledge of a patient’s genetic variations may decrease or increase the chance of developing an adverse drug event or increase or decrease the effectiveness of drug therapy which may have a significant impact on patient outcome.

At the completion of this activity, the participant will be able to:

Pharmacogenomics : Guided therapy in Psychiatry

  1. Use Pharmacogenomics to identify poor metabolizers of drugs or individuals who are ultra rapid metabolizers which can impact the dosing and choice of drugs used.

Pharmacogenomics : Guided therapy in Cardiology  and Oncology

  1. Use Pharmacogenomics to identify poor metabolizers of drugs or individuals who are ultra rapid metabolizers. Participants will be able to use the evidence presented to better choose P2Y12 inhibitors, anti-hypertensives, and optimize warfarin dosing.
  2. Use Pharmacogenomics to identify poor metabolizers of drugs or individuals who are ultra rapid metabolizers. Participants will be able to use the evidence presented to better choose cancer treatments.

Gil-Lichtshein-MD

Expert Speaker

Gil Lichtshein, M.D.

Fellow of The American Psychiatric Association and American Academy of Child and Adolescent Psychiatry and Diplomate of the American Board of Psychiatry and Neurology, certified in psychiatry and child and adolescent psychiatry by the American Board of Psychiatry and Neurology.  Assistant Professor, University of Florida College of Medicine and Affiliate Assistant Professor, Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, FL. Dr. Lichtshein specializes in a variety of disorders including mood disorders, bipolar disorder, depression, anxiety disorders, obsessive compulsive disorder (OCD), panic attacks, and attention deficit disorders (ADD/ADHD).  Dr. Lichstein has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Michele-Weizer-PharmD-BCPS

Expert Speaker

Michele Weizer, Pharm. D, BCPS

Pharmacy Automation and CPOE Lead, Informatics Pharmacist, JFK Medical Center, Atlantis, FL , Clinical Associate Professor, University of Florida, Member, Florida Board of Pharmacy.  Dr. Weizer has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Transcranial Magnetic Stimulation-A novel FDA approved non invasive and non pharmacological treatment for Major Depressive Disorder  (2.5 hrs)

Date: Sunday, 7/1/2018
Check-in: 2:15 PM
Educational Session: 2:30 PM – 5:00 PM

At the completion of this activity, the participant will be able to:

  1. Discuss principles of TMS and neuromodulation.

2. Discuss  its application to the treatment of depression and other disorders.

Gil-Lichtshein-MD

Expert Speaker

Gil Lichtshein, M.D.

Fellow of The American Psychiatric Association and American Academy of Child and Adolescent Psychiatry and Diplomate of the American Board of Psychiatry and Neurology, certified in psychiatry and child and adolescent psychiatry by the American Board of Psychiatry and Neurology.  Assistant Professor, University of Florida College of Medicine and Affiliate Assistant Professor, Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, FL. Dr. Lichtshein specializes in a variety of disorders including mood disorders, bipolar disorder, depression, anxiety disorders, obsessive compulsive disorder (OCD), panic attacks, and attention deficit disorders (ADD/ADHD).  Dr. Lichstein has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Michele-Weizer-PharmD-BCPS

Expert Speaker

Michele Weizer, Pharm. D, BCPS

Pharmacy Automation and CPOE Lead, Informatics Pharmacist, JFK Medical Center, Atlantis, FL , Clinical Associate Professor, University of Florida, Member, Florida Board of Pharmacy.  Dr. Weizer has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Designer Drugs and Opioids:  Identification of Patients who present with manifestation, screening tools, and management. (2.5 hrs)

Date: Thursday, 7/5/2018
Check-in: 2:15 PM
Educational Session: 2:30 PM – 5:00 PM

At the completion of this activity, the participant will be able to:

  1. Review the epidemiology of Opioids, Flakka, Bath Salts and synthetic marijuana as well as other substances of abuse.
  2. Review current national drug use statistics and how it impacts every community and emergency care.
  3. Review the CDC guidelines on opioid prescribing.
  4. Describe typical patient presentation, diagnosis and management.

Gil-Lichtshein-MD

Expert Speaker

Gil Lichtshein, M.D.

Fellow of The American Psychiatric Association and American Academy of Child and Adolescent Psychiatry and Diplomate of the American Board of Psychiatry and Neurology, certified in psychiatry and child and adolescent psychiatry by the American Board of Psychiatry and Neurology.  Assistant Professor, University of Florida College of Medicine and Affiliate Assistant Professor, Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, FL. Dr. Lichtshein specializes in a variety of disorders including mood disorders, bipolar disorder, depression, anxiety disorders, obsessive compulsive disorder (OCD), panic attacks, and attention deficit disorders (ADD/ADHD).  Dr. Lichstein has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Michele-Weizer-PharmD-BCPS

Expert Speaker

Michele Weizer, Pharm. D, BCPS

Pharmacy Automation and CPOE Lead, Informatics Pharmacist, JFK Medical Center, Atlantis, FL , Clinical Associate Professor, University of Florida, Member, Florida Board of Pharmacy.  Dr. Weizer has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Pediatric Autism Spectrum: An Overview (2 hrs)

Drug Shortages and its Impact on Patient Safety and Medication Errors (3 hrs)

Date: Friday, 7/6/2018
Check-in: 7:45 AM
Educational Session: 8:00 AM – 1:30 PM

Pediatric Autism Spectrum: An Overview

At the completion of this activity, the participant will be able to:

  1. Review autism spectrum disorders and discuss changes in diagnosis and classification in DSM V.
  2. Discuss pharmacological treatment options including FDA approved and off label treatment.

Drug Shortages and its Impact on Patient Safety and Medication Errors

This presentation will review how all interplay and impact patient safety at a time when biosimilars (competitive biologics) are edging into the market.

At the completion of this activity, the participant will be able to:

  1. Identify and recognize how when and how flag fatigue can negatively impact patient safety.
  2. Summarize the history behind drug shortages (mergers/acquisitions; state of manufacturer physical plants; lack of quality control).
  3. Discuss the development of “sterile” Compounding Centers to fill gap- which lead to patient harm.
  4. Discuss government implementation of meaningful use- electronic health records and inpatient talking with outpatient demonstrations, CPOE.
  5. Discuss Smart pumps, beside scanning and transfusion scanning, impact for long-term care.
  6. Identify and recognize how when and how flag fatigue can negatively impact patient safety.
  7. Discuss relevant CDS (safety alerts) during CPOE which improve patient safety- allergy alerts, disease interactions, while learning how to turn down nuisance alerts.

Gil-Lichtshein-MD

Expert Speaker

Gil Lichtshein, M.D.

Fellow of The American Psychiatric Association and American Academy of Child and Adolescent Psychiatry and Diplomate of the American Board of Psychiatry and Neurology, certified in psychiatry and child and adolescent psychiatry by the American Board of Psychiatry and Neurology.  Assistant Professor, University of Florida College of Medicine and Affiliate Assistant Professor, Florida Atlantic University, Charles E. Schmidt College of Medicine, Boca Raton, FL. Dr. Lichtshein specializes in a variety of disorders including mood disorders, bipolar disorder, depression, anxiety disorders, obsessive compulsive disorder (OCD), panic attacks, and attention deficit disorders (ADD/ADHD).  Dr. Lichstein has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

Michele-Weizer-PharmD-BCPS

Expert Speaker

Michele Weizer, Pharm. D, BCPS

Pharmacy Automation and CPOE Lead, Informatics Pharmacist, JFK Medical Center, Atlantis, FL , Clinical Associate Professor, University of Florida, Member, Florida Board of Pharmacy.  Dr. Weizer has NO financial arrangements with any corporate organization that might have an interest in the subject being presented.

About The Ship

With nearly 900 cabins with balconies, the Ruby Princess is a unique way to view the spectacular scenery of Alaska.  During scenic cruising, park rangers visit the ship to share their knowledge of this incredible landscape. And if the scenery doesn’t get you, the various on board activities will keep you busy and endless dining options will entice your palate. Discover Alaska on board Ruby Princess!